0001209191-23-011906.txt : 20230222
0001209191-23-011906.hdr.sgml : 20230222
20230222183910
ACCESSION NUMBER: 0001209191-23-011906
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230213
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lutz Robert Matthew
CENTRAL INDEX KEY: 0001786203
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32157
FILM NUMBER: 23655207
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE
STREET 2: SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Savara Inc
CENTRAL INDEX KEY: 0001160308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841318182
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 51285113796
MAIL ADDRESS:
STREET 1: 6836 BEE CAVE ROAD
STREET 2: BUILDING 3, SUITE 201
CITY: AUSTIN
STATE: TX
ZIP: 78746
FORMER COMPANY:
FORMER CONFORMED NAME: Mast Therapeutics, Inc.
DATE OF NAME CHANGE: 20130312
FORMER COMPANY:
FORMER CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20030613
FORMER COMPANY:
FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20010928
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-02-13
1
0001160308
Savara Inc
SVRA
0001786203
Lutz Robert Matthew
6836 BEE CAVE ROAD
BUILDING I, SUITE 205
AUSTIN
TX
78746
0
1
0
0
Chief Operating Officer
The reporting person does not beneficially own any securities of the issuer.
/s/ Robert Matthew Lutz
2023-02-22
EX-24
2
poa.txt
POA DOCUMENT
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS
KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned hereby makes,
constitutes and appoints each of David L. Lowrance and Kathleen R. McCabe, and
each of their successors in the offices of Chief Financial Officer or Senior
Vice President of Legal Affairs of Savara Inc. (the "Company"), as the
undersigned's true and lawful attorney-in-fact (the "Attorney-in Fact"), with
full power of substitution and resubstitution, each with the power to act alone
for the undersigned and in the undersigned's name, place and stead, in any and
all capacities to:
1. prepare, execute, deliver and file with the United States Securities and
Exchange Commission, any national securities exchange and the Company any and
all reports (including any amendment thereto) of the undersigned required or
considered advisable under Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and the rules and regulations thereunder, with
respect to the equity securities of the Company, including Form 3 (Initial
Statement of Beneficial Ownership of Securities), Form 4 (Statement of Changes
in Beneficial Ownership) and Form 5 (Annual Statement of Changes in Beneficial
Ownership) and any successor forms thereto; and
2. seek or obtain, as the undersigned's representative and on the undersigned's
behalf, information on transactions in the Company's equity securities from any
third party, including the Company, brokers, dealers, employee benefit plan
administrators and trustees, and the undersigned hereby authorizes any such
third party to release any such information to the Attorney-in-Fact.
The undersigned acknowledges that:
1. this Limited Power of Attorney authorizes, but does not require, the
Attorney-in-Fact to act at his or her discretion on information provided to such
Attorney-in-Fact without independent verification of such information;
2. any documents prepared and/or executed by the Attorney-in-Fact on behalf of
the undersigned pursuant to this Limited Power of Attorney will be in such form
and will contain such information as the Attorney-in-Fact, in his or her
discretion, deems necessary or desirable;
3. neither the Company nor the Attorney-in-Fact assumes any liability for the
undersigned's responsibility to comply with the requirements of Section 16 of
the Exchange Act, any liability of the undersigned for any failure to comply
with such requirements, or any liability of the undersigned for disgorgement of
profits under Section 16(b) of the Exchange Act; and
4. this Limited Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under Section
16 of the Exchange Act, including, without, limitation, the reporting
requirements under Section 16(a) of the Exchange Act.
The undersigned hereby grants to the Attorney-in-Fact full power and authority
to do and perform each and every act and thing requisite, necessary or
convenient to be done in connection with the foregoing, as fully, to all intents
and purposes, as the undersigned might or could do in person, hereby ratifying
and confirming all that the Attorney-in-Fact, or his or her substitute or
substitutes, shall lawfully do or cause to be done by authority of this Limited
Power of Attorney. This Limited Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4 or 5 with
respect to the undersigned's holdings of and transactions in equity securities
of the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the Attorney-in-Fact. This Limited Power of Attorney shall be
governed and construed in accordance the laws of the State of Texas without
regard to the laws that might otherwise govern under applicable principles of
conflicts of laws thereof.
(Signature page follows.)
IN WITNESS WHEREOF, the undersigned has caused this Limited Power of Attorney
for Section 16(a) Reporting to be executed as of February 22, 2023.
Signature: ___/s/ Robert M. Lutz___________
Print Name: __Robert M. Lutz_______________